PHAR

PHAR

USD

Pharming Group N.V. ADS each representing 10 ordinary shares

$11.140+0.090 (0.814%)

リアルタイム価格

Healthcare
バイオテクノロジー
オランダ

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$11.050

高値

$11.140

安値

$11.050

出来高

0.00M

企業ファンダメンタルズ

時価総額

767.1M

業種

バイオテクノロジー

Netherlands

取引統計

平均出来高

0.00M

取引所

NGM

通貨

USD

52週レンジ

安値 $6.65現在値 $11.140高値 $12.61

関連ニュース

GlobeNewswire

Pharming Group reports first quarter 2025 financial results and provides business update

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, reflecting

もっと見る
Pharming Group reports first quarter 2025 financial results and provides business update
GlobeNewswire

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the

もっと見る
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
GlobeNewswire

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated

もっと見る
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS